SCHEMBL8809365

SCHEMBL8809365

COc1ccc(N(C)CCCSc2ccc(NC(=O)c3cccc4c(=O)c5ccccc5sc34)cc2)cc1OC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ F10 P00742 2/20 0.40
▸ MAPT P10636 6/20 0.40
▸ ALDH1A1 P00352 4/20 0.40
▸ NPC1 O15118 3/20 0.40
▸ RAB9A P51151 3/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ HCRTR1 O43613 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ NFKB1 P19838 1/20 0.40
▸ NFKB2 Q00653 1/20 0.40
▸ RELA Q04206 1/20 0.40
▸ MAOB P27338 1/20 0.38
▸ ADORA2B P29275 1/20 0.38
▸ MAPK1 P28482 2/20 0.37
▸ TP53 P04637 2/20 0.37
▸ SENP5 Q96HI0 2/20 0.37
▸ SENP2 Q9HC62 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8808371 0.89 KDR (0.46) F10MAPTALDH1A1NPC1RAB9A
SCHEMBL8809638 0.89 F10 (0.42) F10MAPTALDH1A1NPC1RAB9A
SCHEMBL8809362 0.88 SMN1; SMN2 (0.43) F10MAPTALDH1A1NPC1RAB9A
SCHEMBL8809575 0.88 F10 (0.41) F10MAPTALDH1A1NPC1RAB9A
SCHEMBL8808106 0.87 F10 (0.41) F10MAPTALDH1A1NPC1RAB9A
SCHEMBL8810132 0.87 KDR (0.45) F10MAPTALDH1A1NPC1RAB9A
SCHEMBL8807954 0.87 F10 (0.43) F10MAPTALDH1A1NPC1RAB9A
SCHEMBL8809375 0.82 MAPT (0.39) F10MAPTALDH1A1NPC1RAB9A
SCHEMBL8807354 0.81 ABCG2 (0.40) F10MAPTALDH1A1NPC1RAB9A
SCHEMBL8807284 0.81 ABCG2 (0.43) F10MAPTALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5663179-A CAN SENSITIZE MULTIDRUG RESISTANT CANCER CELLS TO CHEMOTHERAPEUTIC AGENTS LABORATOIRES GLAXO SA (FR) 1997-09-02 — — US disclosed
EP-0649410-B1 ANILIDE DERIVATIVES GLAXO LAB SA (FR) 1997-05-02 — — EP disclosed
Send feedback